Gastric Adenocarcinoma — Trials

Gastric Adenocarcinoma — Trials · CancerIndex

Clinical trials

Registered studies

447 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 137
Recruiting: 69
Ph III recruiting: 12
Growth YoY: +31.3%
Industry share: 22%
Top sponsor: M.D. Anderson Cancer Center
Termination share: 31.2%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (52)

clinicaltrialsPublishedShowing 1–12 of 12 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT04152499	Phase I-II, FIH, TROP2 ADC, Advanced Unresectable/Metastatic Solid Tumors, Refractory to Standard Therapies (KL264-01)(MK-2870-001)	active not recruiting	Phase 1 / Phase 2	1,410	Klus Pharma Inc.INDUSTRY	6	Sep 17, 2026	clinicaltrials
NCT06399757	A Study to Investigate APL-5125 in Adults With Advanced Solid Tumors	active not recruiting	Phase 1 / Phase 2	100	Apollo Therapeutics LtdINDUSTRY	1	Aug 13, 2026